Us Bancorp \De\ Eli Lilly & CO Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Eli Lilly & CO stock. As of the latest transaction made, Us Bancorp \De\ holds 2,182,569 shares of LLY stock, worth $1.69 Billion. This represents 2.5% of its overall portfolio holdings.

Number of Shares

2,182,569

Previous 2,156,246 1.22%

Holding current value

$1.69 Billion

Previous $1.95 Billion 0.95%

% of portfolio

2.5%

Previous 2.68%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$772.14 - $960.02 $20.3 Million - $25.3 Million	26,323 Added 1.22%	2,182,569 $1.93 Billion
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $21.5 Million - $26.9 Million	29,631 Added 1.39%	2,156,246 $1.95 Billion
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $20.3 Million - $27.1 Million	-34,244 Reduced 1.58%	2,126,615 $1.65 Billion
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $71.6 Million - $84.4 Million	-136,331 Reduced 5.93%	2,160,859 $1.26 Billion
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $2.91 Million - $4.01 Million	6,690 Added 0.29%	2,297,190 $1.23 Billion
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $5.62 Million - $7.51 Million	-16,016 Reduced 0.69%	2,290,500 $1.07 Billion
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $3.33 Million - $3.92 Million	-10,734 Reduced 0.46%	2,306,516 $792 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $54.2 Million - $63.1 Million	168,522 Added 7.84%	2,317,250 $848 Million
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $4.32 Million - $4.92 Million	-14,566 Reduced 0.67%	2,148,728 $695 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $134,905 - $158,398	484 Added 0.02%	2,163,294 $701 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $843,945 - $1.05 Million	3,596 Added 0.17%	2,162,810 $619 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $986,416 - $1.22 Million	-4,387 Reduced 0.2%	2,159,214 $596 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $510,344 - $628,051	-2,303 Reduced 0.11%	2,163,601 $500 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $263,061 - $340,267	1,457 Added 0.07%	2,165,904 $497 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $174,179 - $225,483	1,060 Added 0.05%	2,164,447 $404 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $495,356 - $655,476	-3,797 Reduced 0.18%	2,163,387 $365 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $419,797 - $485,572	2,871 Added 0.13%	2,167,184 $321 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $468,875 - $564,286	-3,437 Reduced 0.16%	2,164,313 $355 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $663,227 - $820,886	5,571 Added 0.26%	2,167,750 $301 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $305,791 - $378,749	-2,860 Reduced 0.13%	2,162,179 $284 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $1.29 Million - $1.4 Million	-12,073 Reduced 0.55%	2,165,039 $242 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $10.1 Million - $11.8 Million	-91,299 Reduced 4.02%	2,177,112 $241 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $2.7 Million - $3.18 Million	-24,264 Reduced 1.06%	2,268,411 $294 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $127,185 - $142,486	-1,201 Reduced 0.05%	2,292,675 $265 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $2.59 Million - $3.24 Million	-30,210 Reduced 1.3%	2,293,876 $246 Million
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $362,527 - $416,068	4,789 Added 0.21%	2,324,086 $198 Million
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $554,422 - $654,459	7,471 Added 0.32%	2,319,297 $179 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $1.96 Million - $2.1 Million	-23,881 Reduced 1.02%	2,311,826 $195 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $180 Million - $200 Million	2,335,707	2,335,707 $200 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account